Hyoscyamine Helps in A-Fib With Slow Ventricular Response

Share this content:

(HealthDay News) -- Hyoscyamine can prevent pacemaker placement in a patient with symptoms caused by a slow ventricular response during atrial fibrillation, according to a case study published online May 15 in the Annals of Internal Medicine.

Scott A. Helgeson, M.D., from the Mayo Clinic in Jacksonville, Fla., and colleagues describe the case of a 98-year-old man with a chronic indwelling urinary catheter, dementia, atrial fibrillation, and metastatic prostate cancer who presented with recurrent syncope and bradycardia to the emergency department. Electrocardiography documented atrial fibrillation with a slow ventricular response and right bundle branch block; blood pressure was 72/40 mm Hg and heart rate was 35 beats/minute.

The researchers decided to try treatment with medication therapy because of the patient's comorbidities. Intravenous glycopyrrolate was administered, and his heart rate increased to 73 beats/minute. A similar but prolonged response was seen after administration of 0.125 mg sublingual immediate-release hyoscyamine. The patient did not develop tachycardia overnight and was discharged the following day while receiving hyoscyamine four times daily. At routine follow-up four weeks later, the patient had experienced no syncope and had a resting heart rate of 73 beats/minute.

"Clinicians may want to attempt this approach in patients with atrial fibrillation who have a slow ventricular response and would qualify for a pacemaker but have comorbidities that make this intervention less desirable," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »